In The News Posted November 15, 2020 Share Posted November 15, 2020 CLEVELAND, Nov. 15, 2020 /PRNewswire/ -- Findings from a new Cleveland Clinic study do not support the use of a high dose omega-3 fatty acid formulation to reduce major adverse cardiovascular events in patients with high cardiovascular risk. Findings from the STRENGTH Trial:...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.